Sunday, May 28, 2023

DCGI

Nasal vaccine to be available as booster for 18+

With India on alert amid a Covid-19 boom in China and several other countries, Bharat Biotech’s first-of-its-kind needle-free intranasal vaccine will now be available as a booster dose for all adults, sources told News18.The Hyderabad-based Covaxin maker’s nasal vaccine...

Cough syrup deaths: Panel to study WHO report

The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough...

Cough syrup samples sent for checking: Haryana govt after WHO alert

The government on Thursday said samples of cough syrups manufactured by an Indian firm allegedly linked to the deaths of children in Gambia have been sent for testing by drug regulator DCGI and its results will guide further course...

DCGI nod to intranasal Covid vaccine

Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech’s intranasal Covid vaccine for restricted emergency use in those aged above 18 years.“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal...

Panel approves use of Covovax for 7-11 year olds

An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Serum Institute’s Covovax for children aged 7 to 11 years, official sources said.The recommendation has been sent to Drugs Controller General of India...

BE’s Covid-19 vaccine Corbevax gets DCGI nod as heterologous booster dose

Biological E Limited on Saturday announced that its COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose.The vaccine maker said the Corbevax can be administered as a booster dose...

PM to interact with CMs on Covid situation today

Prime Minister Narendra Modi will interact with chief ministers on the emerging COVID-19 situation in the country on Wednesday through video conferencing, an official said.Union Health Secretary Rajesh Bhushan will make a presentation at the conference.“PM Modi will interact...

Govt panel recommends Corbevax for emergency use among 12 to 18-year-olds

An expert panel of the country’s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E’s COVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, of-ficial sources said.The Central government...